Morgan Stanley’s US Physical Therapy USPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $75.1M | Sell |
1,002,468
-865
| -0.1% | -$70.9K | ﹤0.01% | 1696 |
|
|
2025
Q4 | $78.4M | Sell |
1,003,333
-129,484
| -11% | -$10.5M | ﹤0.01% | 1665 |
|
|
2025
Q3 | $96.2M | Buy |
1,132,817
+84,912
| +8% | +$6.8M | 0.01% | 1436 |
|
|
2025
Q2 | $81.9M | Buy |
1,047,905
+52,449
| +5% | +$3.87M | 0.01% | 1492 |
|
|
2025
Q1 | $72M | Sell |
995,456
-41,728
| -4% | -$3.5M | 0.01% | 1492 |
|
|
2024
Q4 | $92M | Sell |
1,037,184
-167,614
| -14% | -$14.9M | 0.01% | 1319 |
|
|
2024
Q3 | $102M | Buy |
1,204,798
+5,277
| +0.4% | +$468K | 0.01% | 1221 |
|
|
2024
Q2 | $111M | Buy |
1,199,521
+59,553
| +5% | +$6.02M | 0.01% | 1111 |
|
|
2024
Q1 | $129M | Sell |
1,139,968
-1,093,522
| -49% | -$109M | 0.01% | 1025 |
|
|
2023
Q4 | $208M | Buy |
2,233,490
+1,253,914
| +128% | +$110M | 0.01% | 1126 |
|
|
2023
Q3 | $89.9M | Buy |
979,576
+36,680
| +4% | +$3.94M | 0.01% | 1128 |
|
|
2023
Q2 | $114M | Buy |
942,896
+152,918
| +19% | +$16.5M | 0.01% | 1008 |
|
|
2023
Q1 | $77.3M | Buy |
789,978
+87,808
| +13% | +$8.38M | 0.01% | 1214 |
|
|
2022
Q4 | $56.9M | Buy |
702,170
+571,710
| +438% | +$48M | 0.01% | 1393 |
|
|
2022
Q3 | $9.92M | Sell |
130,460
-36,516
| -22% | -$3.51M | ﹤0.01% | 2994 |
|
|
2022
Q2 | $18.2M | Buy |
166,976
+39,045
| +31% | +$4.15M | ﹤0.01% | 2396 |
|
|
2022
Q1 | $12.7M | Sell |
127,931
-52,472
| -29% | -$5M | ﹤0.01% | 2617 |
|
|
2021
Q4 | $17.2M | Buy |
180,403
+63,372
| +54% | +$6.35M | ﹤0.01% | 2316 |
|
|
2021
Q3 | $12.9M | Buy |
117,031
+17,404
| +17% | +$1.98M | ﹤0.01% | 2590 |
|
|
2021
Q2 | $11.5M | Buy |
99,627
+11,266
| +13% | +$1.29M | ﹤0.01% | 2821 |
|
|
2021
Q1 | $9.2M | Buy |
88,361
+42,469
| +93% | +$5.28M | ﹤0.01% | 2740 |
|
|
2020
Q4 | $5.52M | Buy |
45,892
+9,565
| +26% | +$965K | ﹤0.01% | 3156 |
|
|
2020
Q3 | $3.15M | Sell |
36,327
-58,381
| -62% | -$5.02M | ﹤0.01% | 3192 |
|
|
2020
Q2 | $7.67M | Sell |
94,708
-53,610
| -36% | -$3.91M | ﹤0.01% | 2223 |
|
|
2020
Q1 | $10.2M | Buy |
148,318
+66,390
| +81% | +$7M | ﹤0.01% | 1750 |
|
|
2019
Q4 | $9.37M | Sell |
81,928
-105,232
| -56% | -$13.1M | ﹤0.01% | 2499 |
|
|
2019
Q3 | $24.4M | Buy |
187,160
+124,175
| +197% | +$16.2M | 0.01% | 1340 |
|
|
2019
Q2 | $7.72M | Buy |
62,985
+12,283
| +24% | +$1.41M | ﹤0.01% | 2443 |
|
|
2019
Q1 | $5.33M | Sell |
50,702
-4,102
| -7% | -$441K | ﹤0.01% | 2643 |
|
|
2018
Q4 | $5.61M | Sell |
54,804
-41,847
| -43% | -$4.65M | ﹤0.01% | 2765 |
|
|
2018
Q3 | $11.5M | Buy |
96,651
+43,074
| +80% | +$4.87M | ﹤0.01% | 2270 |
|
|
2018
Q2 | $5.14M | Sell |
53,577
-20,289
| -27% | -$1.88M | ﹤0.01% | 3107 |
|
|
2018
Q1 | $6.01M | Buy |
73,866
+6,221
| +9% | +$482K | ﹤0.01% | 2835 |
|
|
2017
Q4 | $4.88M | Sell |
67,645
-17,306
| -20% | -$1.18M | ﹤0.01% | 3130 |
|
|
2017
Q3 | $5.22M | Buy |
84,951
+5,340
| +7% | +$325K | ﹤0.01% | 2921 |
|
|
2017
Q2 | $4.81M | Buy |
79,611
+20,991
| +36% | +$1.34M | ﹤0.01% | 2882 |
|
|
2017
Q1 | $3.83M | Sell |
58,620
-5,908
| -9% | -$419K | ﹤0.01% | 3153 |
|
|
2016
Q4 | $4.53M | Sell |
64,528
-28,738
| -31% | -$1.83M | ﹤0.01% | 3103 |
|
|
2016
Q3 | $5.85M | Buy |
93,266
+50,968
| +120% | +$3.14M | ﹤0.01% | 2518 |
|
|
2016
Q2 | $2.55M | Buy |
42,298
+921
| +2% | +$50.5K | ﹤0.01% | 3225 |
|
|
2016
Q1 | $2.06M | Buy |
41,377
+31,003
| +299% | +$1.54M | ﹤0.01% | 3329 |
|
|
2015
Q4 | $557K | Sell |
10,374
-2,620
| -20% | -$131K | ﹤0.01% | 4471 |
|
|
2015
Q3 | $583K | Sell |
12,994
-13,668
| -51% | -$681K | ﹤0.01% | 4505 |
|
|
2015
Q2 | $1.46M | Buy |
26,662
+10,321
| +63% | +$511K | ﹤0.01% | 3912 |
|
|
2015
Q1 | $777K | Sell |
16,341
-23,144
| -59% | -$984K | ﹤0.01% | 4321 |
|
|
2014
Q4 | $1.66M | Sell |
39,485
-408
| -1% | -$16.1K | ﹤0.01% | 3724 |
|
|
2014
Q3 | $1.41M | Sell |
39,893
-3,156
| -7% | -$112K | ﹤0.01% | 3737 |
|
|
2014
Q2 | $1.47M | Buy |
43,049
+35,775
| +492% | +$1.15M | ﹤0.01% | 3732 |
|
|
2014
Q1 | $252K | Sell |
7,274
-17,265
| -70% | -$573K | ﹤0.01% | 4992 |
|
|
2013
Q4 | $865K | Buy |
24,539
+5,858
| +31% | +$192K | ﹤0.01% | 4041 |
|
|
2013
Q3 | $581K | Sell |
18,681
-10,670
| -36% | -$315K | ﹤0.01% | 4231 |
|
|
2013
Q2 | $812K | Buy |
+29,351
| New | +$776K | ﹤0.01% | 3888 |
|
Other funds holding USPH
BG
CCM
VCM
SAM
BTW
Morgan Stanley's USPH Position: Q1 2026 in Review
Morgan Stanley reduced its US Physical Therapy (USPH) stake by 0.09% in Q1 2026, selling an estimated $70.9K and leaving 1,002,468 shares worth $75.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1696.
Morgan Stanley first reported a position in USPH in Q2 2013 and has held it in 52 quarters since. The position peaked at $208M in Q4 2023. 229 funds tracked by Wall St. Rank hold USPH as of Q1 2026.
- Morgan Stanley held 1,002,468 shares of US Physical Therapy worth $75.1M as of Q1 2026.
- Morgan Stanley sold 865 US Physical Therapy shares in Q1 2026, an estimated $70.9K.
- US Physical Therapy made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #1696 holding.
- Morgan Stanley first reported a position in US Physical Therapy in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's US Physical Therapy position peaked at $208M in Q4 2023.
- 229 funds tracked by Wall St. Rank held US Physical Therapy as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.